CD Biosynsis offers a comprehensive suite of Chlamydomonas reinhardtii Genome Editing and Metabolic Engineering Solutions, transforming this premier photosynthetic model into a high-efficiency green cell factory. As a versatile chassis for biofuels, high-value pigments, and recombinant therapeutics, Chlamydomonas reinhardtii requires sophisticated genetic control to overcome its unique biological hurdles, such as high GC-content and robust gene silencing. Our platform integrates precision CRISPR-based technologies with advanced systems biology to provide reliable, scalable engineering solutions for both academic research and industrial biotechnology.
Our solutions focus on the rational design of algal strains by coordinating the complex interplay between the nuclear and chloroplast genomes. We utilize DNA-free Ribonucleoprotein (RNP) delivery to ensure high editing efficiency and genomic stability, bypassing the limitations of traditional insertional mutagenesis. Whether your goal is to redirect carbon flux from starch to lipids, enhance photosynthetic light-harvesting efficiency, or produce complex human proteins, our integrated approach delivers verified monoclonal strains with optimized metabolic performance and robust growth characteristics.
Get a QuoteMetabolic engineering in Chlamydomonas reinhardtii demands a holistic view of the cell's energetic and carbon fixation pathways. Our platform addresses these complexities by combining site-specific genome editing with predictive computational modeling. We utilize Flux Balance Analysis (FBA) to map metabolic bottlenecks and identify key genetic targets that govern nutrient utilization and byproduct formation. By fine-tuning these nodes, we can significantly increase the titer, rate, and yield of your target molecule while maintaining the physiological health of the algal culture.
Furthermore, our engineering solutions emphasize the stability of the modified phenotype. We employ specialized algal vectors featuring native introns and promoters proven to sustain high-level transgene expression. Our focus on monoclonality and long-term stability testing ensure that the engineered traits remain fixed throughout large-scale cultivation in photobioreactors, providing a reliable foundation for sustainable biomanufacturing and carbon capture initiatives.
Integrated platforms for nuclear and chloroplast engineering using high-efficiency RNP delivery systems.
Optimized CRISPR-Cas9/Cas12a nuclease platforms tailored for the 64 percent GC-content of the algal nucleus.
Permanent and precise disruption of target genes to study functional genomics or eliminate competitive metabolic pathways.
Site-specific integration of reporters or pathways into validated safe harbor loci for reliable expression.
Tunable and reversible gene knockdown, ideal for studying essential genes and metabolic flux balancing.
DNA-break-free single-nucleotide conversion for precise protein engineering and single-residue substitutions.
Rational redirection of carbon and energy flux to maximize the production of biofuels and high-value metabolites.
High-throughput development and screening of robust algal strains optimized for industrial photobioreactors.
Simultaneous disruption of redundant gene families or complex metabolic branches to create clean chassis strains.
Production and purification of recombinant proteins with eukaryotic folding and post-translational modifications.
Quantitative phenotyping and genome-scale metabolic modeling to predict and validate engineered strain performance.
Our systematic Design-Build-Test-Learn cycle ensures precision and reproducibility in every Chlamydomonas reinhardtii project.
1. Computational Design
2. Genetic Build
3. High-Throughput Test
4. Learn & Verify
Establish metabolic flux models and perform codon optimization for the algal chassis. Identify high-specificity gRNAs targeting nuclear or chloroplast loci.
Transformation via optimized electroporation or biolistic delivery. Simultaneous multi-gene editing using pre-assembled RNP complexes.
Verification: Genotype confirmation via NGS and functional stability assessment over multiple passages. Data-driven refinement for subsequent engineering cycles.
Cross-Genomic Engineering
Concurrent optimization of nuclear and chloroplast genomes for total control over photosynthesis and secondary metabolism.
DNA-Free RNP Delivery
Eliminating transgene silencing and off-target integrations, ensuring the most reliable phenotypes in the Chlamydomonas model.
Predictive Flux Modeling
Utilizing genome-scale models to identify targets, reducing laboratory turnaround time and maximizing production yields.
Industrial Stability
Focus on site-specific integration and monoclonal verification ensures strains perform consistently in large-scale production environments.
1. How do you address the high GC-content of the Chlamydomonas genome?
We utilize specialized gRNA design algorithms and nuclease variants specifically validated for high-GC environments, combined with full-gene codon optimization to ensure high translation efficiency.
2. Can you target both the nucleus and the chloroplast in the same project?
Yes. Our dual-genome engineering platform allows for sequential or simultaneous modification of both compartments, which is essential for optimizing complex photosynthetic pathways.
3. Why use RNP delivery for Chlamydomonas reinhardtii?
RNPs provide transient activity and do not integrate into the genome, avoiding the robust gene silencing mechanisms of the algal host and providing cleaner, more predictable phenotypes.
4. How do you verify the stability of engineered metabolic pathways?
Strains undergo stability trials over 30 to 50 passages, followed by metabolic flux analysis and NGS to ensure the genetic modifications and phenotypic performance remain constant.
5. What is the benefit of CRISPRi over traditional knockout for essential genes?
CRISPRi allows for tunable gene knockdown rather than complete disruption, making it possible to study the function of essential genes involved in photosynthesis or cell division without causing lethality.
6. Do you offer help with metabolic modeling of new pathways?
Yes, we offer genome-scale metabolic reconstruction and Flux Balance Analysis (FBA) to predict the most effective genetic targets for introducing or optimizing exogenous metabolic pathways.
7. How is monoclonal purity ensured in the screening process?
We utilize automated single-cell isolation (FACS or microfluidics) followed by high-throughput agar plating and PCR-based junction verification to guarantee 100% monoclonal clones.
8. What is the typical turnaround time for a customized algal strain?
Depending on the complexity, a standard project from computational design to the delivery of a verified monoclonal strain typically ranges from 16 to 22 weeks.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.